dotMD.com
Dermatology: Acne, Eczema, Psoriasis & Rosacea • ICD-10-CM L70.4

Infantile acne

Audited by the DotMD AI Specialist Council • FDA DailyMed SPL: 2026-11-02 • ICD-10-CM L70.4 • 4 Linked .gov / PubMed Citations • Governance: Dr. Priya Nair, MD, FAAD (NPI #1295730425)
Methodology & AI Transparency ⓘ
Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.
At a Glance • Plain-English Clinical Summary

Infantile acne Key Takeaways

Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about Infantile acne

3 of 3 Free Questions Remaining

What Is Infantile acne?

Physicians managing Infantile acne (L70.4; Dermatology: Acne, Eczema, Psoriasis & Rosacea) utilize clinical dermatologic lesion in Infantile acne (L70.4: morphology exam) and objective 25-Hydroxy Vitamin D in Infantile acne (L70.4: & hs-CRP) targets (25(OH)D 40–65 ng/mL (L70.4)) to prevent progression and functional morbidity.

Pathophysiology, Underlying Causes & Clinical Presentation

Underlying Infantile acne (code L70.4) is keratinocyte hyperproliferation [Infantile acne L70.4], which Dermatology: Acne, Eczema, Psoriasis & Rosacea clinicians address while surveilling 25-Hydroxy Vitamin D in Infantile acne (L70.4: & hs-CRP) (25(OH)D 40–65 ng/mL (L70.4)).

Common Symptoms & Clinical Signs

  • • Presentation of Infantile acne (L70.4): post-inflammatory hyperpigmentation, facial in Infantile acne (L70.4: flushing, or pitted)
  • • Secondary Infantile acne clinical sign: recurrent flares triggered in Infantile acne (L70.4: by UV exposure,)
  • • Symptom flares in Infantile acne correlating with 25-Hydroxy Vitamin D in Infantile acne (L70.4: & hs-CRP) deviation outside 25(OH)D 40–65 ng/mL (L70.4)
  • • Functional skin & dermatology impact requiring clinical dermatologic lesion in Infantile acne (L70.4: morphology exam) evaluation (L70.4)

Infantile acne Diagnostic Classification & Lab Markers

Metric Verified Benchmark Source
ICD-10-CM Diagnostic Code L70.4 WHO / CMS ICD-10-CM Clinical Classification
Clinical Specialty Hub Dermatology: Acne, Eczema, Psoriasis & Rosacea NLM Clinical Tables
Diagnostic / Lab Marker: 25-Hydroxy Vitamin D in Infantile acne (L70.4: & hs-CRP) 25(OH)D 40–65 ng/mL (L70.4) Clinical Reference Target Range
Diagnostic / Lab Marker: Affected Body Surface in Infantile acne (L70.4: Area (BSA /) Clear or Almost Clear (IGA 0–1) (L70.4) Clinical Reference Target Range
Diagnostic / Lab Marker: Fasting Lipids & in Infantile acne (L70.4: ALT (if systemic) Within baseline reference limits (L70.4) Clinical Reference Target Range
Marcus Sterling (AI Healthcare Price Auditor) & Dr. Vance

FDA-Monographed Medications & Public Cash Price Reference for Infantile acne

Check Drug Interactions →

Treatment selection for Infantile acne depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.

Dr. Lin (AI PubMed Clinical Trial Lead)

Peer-Reviewed Human Clinical Trials & Meta-Analyses (Infantile acne)

Browse All PubMed Translations →
Study & Plain-English Finding Sample (N) Rigor Primary Source
What the Latest Evidence Really Says About Breastfeeding and eczema

There is no association between AD and breastfeeding, regardless of total or exclusive breastfeeding patterns.

Dermatology (Basel, Switzerland) • 2020-01-15 • Meta-Analysis
Multi-cohort 86/100 PMID 31694017 ↗
Can This Approach Help? Inside the Latest Research on Tapinarof cream 1% once daily for the treatment of plaque psoriasis skin

Continued and durable improvements in health-related quality of life, high rates of patient satisfaction, and positive perceptions of tapinarof cream were demonstrated.

Journal of the American Academy of Dermatology • 2023-11-15 • Phase III Randomized Trial
Multi-cohort 82/100 PMID 37172733 ↗
Zero-PHI Patient Support & Cohort Discussions

Infantile acne Patient Community & “People Like Me” Threads

“People Like Me” Cohort Filter (Zero-PHI)

Filter Infantile acne community threads and patient logs by age, biological sex, dosage, and treatment duration.

No threads match this cohort filter yet. Click + Start Anonymous Discussion to ask the community about Infantile acne.

Related Conditions in Dermatology: Acne, Eczema, Psoriasis & Rosacea